Sharp Therapeutics【SHRX】銘柄情報

Sharp Therapeutics Corp (SHRX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.00

( - )

買値

0.01

売値

3.90

出来高

0.00 日の範囲 0.00

0.23 52 週間の範囲 5.00

時価総額

30.076M

前日終値

1.00

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 250

発行済株式数

30,075,700

配当利回り

PER

-7.31

1 株当たり利益 (EPS)

-0.21

歳入

純利益

-6.17M

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery ... Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a custom-built, cloud-distributed analytics platform that captures data for AlloChem compounds in CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

sharptx.com

本社

Pittsburgh, United States

設立

Sharp Therapeutics Corp is listed in the Healthcare sector of the トロントベンチャー取引所 with ticker SHRX. The last closing price for Sharp Therapeutics was $1. Over the last year, Sharp Therapeutics shares have traded in a share price range of $ 0.23 to $ 5.00.

Sharp Therapeutics currently has 30,075,700 shares in issue. The market capitalisation of Sharp Therapeutics is $30.08 million. Sharp Therapeutics has a price to earnings ratio (PE ratio) of -7.31.

Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board

PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company...

Sharp Therapeutics to Present Pipeline and Program Updates at World Orphan Drug Congress 2025

PITTSBURGH, Pa. and TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.1	-52.380952381	2.1	2.1	1	260	1	CS
4	-1.1	-52.380952381	2.1	2.1	1	65	1	CS
12	-1.25	-55.5555555556	2.25	2.25	1	32	1.32343324	CS
26	-1.5	-60	2.5	2.5	1	483	2.2314409	CS
52	-0.85	-45.9459459459	1.85	5	0.23	895	2.72304304	CS
156	0.78	354.545454545	0.22	5	0.22	755	2.57351207	CS
260	0.78	354.545454545	0.22	5	0.22	755	2.57351207	CS